** Shares of Viagra and Xanax maker Viatris VTRS.O fall 3.6% to $15.5 premarket
** Co expects 2026 adjusted profit in the range of $2.33 and $2.47 per share, below analysts' average estimate of $2.49 per share, according to data compiled by LSEG
** Co posted Q4 revenue of $3.70 billion, beating estimates of $3.53 billion
** Co reports Q4 adjusted profit of 57 cents vs. estimates of 53 cents
** VTRS said in its earnings release that it expects regulatory decisions for six products this year
** VTRS stock was up 29.2% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))